Clinical trial
Observational and Cross-sectional Study to Assess the Sociodemographic and Clinical Characteristics of Patients Treated With RIVAROXABAN in the Context of Routine Clinical Practice of Spanish Haematologists, Cardiologists and Internists (HEROIC Study)
NCT02262676 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational and Cross-sectional Study to Assess the Sociodemographic and Clinical Characteristics of Patients Treated With RIVAROXABAN in the Context of Routine Clinical Practice of Spanish Haematologists, Cardiologists and Internists (HEROIC Study)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- May 31, 2015
- Enrollment
- 2,251 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.